A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 productionNAIR, A. P. K; DIAMANTIS, I. D; CONSCIENCE, J.-F et al.Molecular and cellular biology (Print). 1989, Vol 9, Num 3, pp 1183-1190, issn 0270-7306, 8 p.Article

Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinaseSIU-POK YEE; MOCK, D; GREER, P et al.Molecular and cellular biology (Print). 1989, Vol 9, Num 12, pp 5491-5499, issn 0270-7306, 9 p.Article

Pleiotropic Action of AP-1 in v-Src-Transformed CellsLIZHEN WANG; RODRIGUES, Natalie A; YING WU et al.Journal of virology. 2011, Vol 85, Num 13, pp 6725-6735, issn 0022-538X, 11 p.Article

Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc conditional regulation of c-myc transcription by temperature-sensitive v-ablCLEVELAND, J. L; DEAN, M; ROSENBERG, N et al.Molecular and cellular biology (Print). 1989, Vol 9, Num 12, pp 5685-5695, issn 0270-7306, 11 p.Article

Constitutive phosphorylation of a Rac GAP MgcRacGAP is implicated in v-Src-induced transformation of NIH3T3 cellsDOKI, Noriko; KAWASHIMA, Toshiyuki; NOMURA, Yasushi et al.Cancer science. 2009, Vol 100, Num 9, pp 1675-1679, issn 1347-9032, 5 p.Article

Increased Bcl-x_L expression mediates v-Src-induced resistance to anoikis in intestinal epithelial cellsLOZA COLL, Mariano; ROSEN, Kirill; LADEDA, Virginia et al.Oncogene (Basingstoke). 2002, Vol 21, Num 18, pp 2908-2913, issn 0950-9232Article

Mechanisms of tumor induction by human retrovirusesFERDINAND, F.-J.Arzneimittel-Forschung. 1989, Vol 39, Num 6, pp 737-740, issn 0004-4172Article

Novel insights into c-Src : Anti-cancer drugsALPER, Ö; BOWDEN, E. T.Current pharmaceutical design. 2005, Vol 11, Num 9, pp 1119-1130, issn 1381-6128, 12 p.Article

Two-dimensional electrophoretic analysis of transformation-sensitive polypeptides during chemically, spontaneously, and oncogene-induced transformation of rat liver epithelial cellsWIRTH, P. J; LUO, L.-D; FUJIMOTO, Y et al.Electrophoresis (Weinheim. Print). 1992, Vol 13, Num 5, pp 305-320, issn 0173-0835Article

SV40 T-antigen is required for maintenance of immortal growth in SV40-transformed human fibroblastsTSUYAMA, N; MIURA, M; KITAHIRA, M et al.Cell structure and function. 1991, Vol 16, Num 1, pp 55-62, issn 0386-7196Article

Immortalization of primary cells by DNA tumor virusesLINDER, S; MARSHALL, H.Experimental cell research. 1990, Vol 191, Num 1, pp 1-7, issn 0014-4827, 7 p.Article

The emerging genetics of cancerSKINNER, M. A; IGLEHART, J. D.Surgery, gynecology & obstetrics. 1989, Vol 168, Num 4, pp 371-379, issn 0039-6087Article

Oncogenes from hormone receptorsPARKER, M. G.Journal of endocrinology. 1987, Vol 112, Num 1, pp 1-2, issn 0022-0795Article

DNA vaccination against v-src oncogene-induced tumours in congenic chickensPLACHY, Jiri; HEJNAR, Jiri; TRTKOVA, Katerina et al.Vaccine. 2001, Vol 19, Num 31, pp 4526-4535, issn 0264-410XConference Paper

Prediction of homologous binding sites on RB and 107 common for viral oncoproteins and cellular ligandsWENDTNER, C. M; RADULESCU, R. T.JMR. Journal of molecular recognition. 1992, Vol 5, Num 4, pp 125-132, issn 0952-3499Article

Inhibition of epidermal growth factor receptor biosynthesis caused by the src oncogene product, pp60^v-srcWASILENKO, W. J; NORI, M; TESTERMAN, N et al.Molecular and cellular biology (Print). 1990, Vol 10, Num 3, pp 1254-1258, issn 0270-7306, 5 p.Article

Viral oncogenes and signal transductionSTORMS, R. W; BOSE, H. R. JR.Virus research. 1989, Vol 12, Num 3, pp 251-282, issn 0168-1702Article

The v-erbA oncogene is a thyroid hormone receptor antagonistEVANS, R. M.International journal of cancer. 1989, pp 26-28, issn 0020-7136, suppl. 4Conference Paper

v-juin is a transcriptional activator, but not in all cell-linesIMLER, J. I; UGARTE, E; WASYLYK, C et al.Nucleic acids research. 1988, Vol 16, Num 7, pp 3005-3012, issn 0305-1048Article

Histogenesis and clonality of pancreatic tumors induced by ν-myc and ν-raf oncogenes in NFS/N miceFREDRICKSON, T. N; HARTLEY, J. W; WOLFORD, N. K et al.The American journal of pathology. 1988, Vol 131, Num 3, pp 444-451, issn 0002-9440Article

Effects of phosphorylation of protein phosphatase 1 by pp60^v-src on the interaction of the enzyme with substrates and inhibitor proteinsJOHANSEN, J. W; INGEBRITSEN, T. S.Biochimica et biophysica acta. 1987, Vol 928, Num 1, pp 63-75, issn 0006-3002Article

The v-erbA oncogene blocks expression of α2/β1 integrin a normal inhibitor of erythroid progenitor proliferationMEY, Anne; GANDRILLON, Olivier; MCNAGNY, Kelly M et al.Oncogene (Basingstoke). 2002, Vol 21, Num 18, pp 2864-2872, issn 0950-9232Article

Transformation by v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factorsCLARK, W; GILLESPIE, D. A. F.Cell growth and differentiation. 1997, Vol 8, Num 4, pp 371-380, issn 1044-9523Article

Infection with a Kirsten-retrovirus can induce a multiplicity of tumorigenic phenotypes in the interleukin-3-dependent FDC-P1 cellsDUMENIL, D; NEEL, H; LACOUT, C et al.Experimental hematology. 1994, Vol 22, Num 2, pp 178-185, issn 0301-472XArticle

The discovery of ras and its biological importanceWEINBERG, R. A.Handbook of experimental pharmacology. 1993, Vol 108, pp 249-258, issn 0171-2004, 1Article